SCHEMBL23762190

SCHEMBL23762190

CC(C)(C)OC(=O)N1CCc2ccc(Oc3ccnc4c3c(C(=O)O)cn4COCCS(C)(C)C)cc2C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1H2 P55055 1/20 0.40
▸ ACACB O00763 1/20 0.37
▸ ESR2 Q92731 1/20 0.37
▸ MAPT P10636 2/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ TSHR P16473 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ USP2 O75604 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ F10 P00742 4/20 0.34
▸ PLG P00747 1/20 0.34
▸ PRSS1 P07477 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23762183 0.93 NR1H2 (0.39) NR1H2ACACBESR2MAPTF10
SCHEMBL23762170 0.92 NR1H2 (0.41) NR1H2ACACBESR2MAPTF10
SCHEMBL22802663 0.91 NR1H2 (0.41) NR1H2ACACBESR2MAPTF10
SCHEMBL23751283 0.91 NR1H2 (0.41) NR1H2ACACBESR2MAPTKDM4E
SCHEMBL23762088 0.91 NR1H2 (0.41) NR1H2ACACBESR2MAPTF10
SCHEMBL23762200 0.89 NR1H2 (0.39) NR1H2ACACBESR2F10PLG
SCHEMBL23762154 0.89 NR1H2 (0.39) NR1H2ACACBESR2MAPTF10
SCHEMBL23762264 0.88 NR1H2 (0.36) NR1H2ACACBESR2MAPTKDM4E
SCHEMBL23762173 0.88 NR1H2 (0.38) NR1H2ACACBESR2MAPTF10
SCHEMBL23762144 0.87 NR1H2 (0.40) NR1H2ACACBESR2MAPTF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210253568-A1 AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2021-08-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210253568-A1 AZAINDOLE DERIVATIVES AS RHO-KINASE INHIBITORS ROCK1, ROCK2, RHOA NR1H2 1422/4885ACACB 2494/4885ESR2 3940/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback